We recently published a list of 20 Takeover Rumors Hedge Funds Are Buying. In this article, we are going to take a look at ...

UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging ...

Vanda Pharmaceuticals is suing the FDA again, this time alleging the agency is unlawfully delaying a hearing to discuss the ...

Statistically significant improvements observed across clinical endpoints; final cohort results expected in Q2 2025 ...

Wolf conservationists say the truly dire matter is protecting America’s wild gray wolves — but that’s not as cute and cuddly ...

“We were given the opportunity to engage with Genentech in 1977, two years before its IPO [initial public offering], and we ...

A 1975 meeting at the Asilomar Conference Center in Pacific Grove, California, shaped a new safety regime for recombinant DNA ...

Find out why Europe has fallen behind the U.S. and China in the AI race in biotech and what it needs to do to catch up.

Initiation by Merck of a Phase 2 trial in Alzheimer’s disease with partnered α7 nicotinic acetylcholine receptor PAM MK-1167 highlights company’s ...

Tharimmune, Inc. (NASDAQ:THAR), a clinical-stage biotechnology company advancing novel solutions in immunology and oncology, today announced the appointment of Vincent LoPriore, Founder of Gravitas ...

A company recently claimed it revived an extinct species, launching a debate across scientific and conservation communities.

Life sciences have always been about breakthroughs, but the pandemic revealed a sobering truth: speed and scale are th ...